Baillie Gifford PACIRA PHARMACEUTICALS INC ownership

Watchlist

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 267 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Baillie Gifford ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$72,074,870
+73232.5%
1,866,741
+1.0%
0.08%
-25.7%
Q3 2022$98,285
-12.9%
1,847,797
-4.5%
0.10%
-12.9%
Q2 2022$112,796
-30.3%
1,934,752
-8.7%
0.12%
+2.7%
Q1 2022$161,767
+14.2%
2,119,600
-10.0%
0.11%
+44.9%
Q4 2021$141,714
+21.2%
2,355,240
+12.8%
0.08%
+27.9%
Q3 2021$116,917
-8.4%
2,087,807
-0.7%
0.06%
-1.6%
Q2 2021$127,595
-13.1%
2,102,759
+0.3%
0.06%
-24.4%
Q1 2021$146,872
+25.0%
2,095,481
+6.7%
0.08%
+26.2%
Q4 2020$117,513
+11.1%
1,963,795
+11.6%
0.06%
-11.0%
Q3 2020$105,750
+38.1%
1,758,989
+20.5%
0.07%
+25.9%
Q2 2020$76,587
+61.8%
1,459,626
+3.4%
0.06%
+13.7%
Q1 2020$47,341
-24.7%
1,411,892
+1.8%
0.05%
-16.4%
Q4 2019$62,852
+43.4%
1,387,445
+20.5%
0.06%
+22.0%
Q3 2019$43,845
+1.3%
1,151,710
+15.8%
0.05%
+8.7%
Q2 2019$43,265
+14.7%
994,839
+0.4%
0.05%
+12.2%
Q1 2019$37,715
-6.1%
990,908
+6.1%
0.04%
-21.2%
Q4 2018$40,161
+1.9%
933,541
+16.4%
0.05%
+20.9%
Q3 2018$39,418
+111.3%
802,009
+37.8%
0.04%
+115.0%
Q2 2018$18,653
+17.4%
582,000
+14.1%
0.02%
+5.3%
Q1 2018$15,890
-6.0%
510,097
+37.8%
0.02%
-9.5%
Q4 2017$16,898
+40.4%
370,162
+15.5%
0.02%
+40.0%
Q3 2017$12,038
-16.2%
320,582
+6.5%
0.02%
-21.1%
Q2 2017$14,358
+47.4%
301,000
+40.9%
0.02%
+35.7%
Q1 2017$9,740
+41.2%
213,6000.0%0.01%
+27.3%
Q4 2016$6,899
-5.6%
213,6000.0%0.01%0.0%
Q3 2016$7,309
+1.4%
213,6000.0%0.01%
-15.4%
Q2 2016$7,205
+394.5%
213,600
+676.7%
0.01%
+333.3%
Q1 2016$1,457
-27.6%
27,500
+5.0%
0.00%0.0%
Q4 2015$2,012
+86.8%
26,2000.0%0.00%
+50.0%
Q3 2015$1,077–26,200–0.00%–
 Download

External links